2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 6 of 36 drug pricing articles
CAR-T Therapy Cost in 2026: How Much Does It Really Cost in the U.S.? - 2026 Drug Cost Analysis

CAR-T Therapy Cost in 2026: How Much Does It Really Cost in the U.S.?

6 views

CAR-T therapy is transforming cancer treatment—but its cost remains among the highest in modern medicine. In 2026, total U.S. treatment expenses often range from $500,000 to over $1 million, depending on hospital, insurance coverage, and side-effect management. This guide breaks down updated CAR-T therapy prices, real-world cost data, insurance options, and expert forecasts for future affordability. Learn how patients can prepare financially and explore assistance programs that make this life-saving therapy more accessible.

How Much Does Keytruda Cost with Insurance in the U.S.? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost with Insurance in the U.S.?

33 views

In 2026, most patients pay between $300 and $3,000 per month depending on their plan, deductible, and location. This complete guide breaks down Keytruda prices with and without insurance, Medicare coverage, patient assistance programs, and expert insights to help Americans save on cancer treatment costs.

Keytruda Cost in 2026: Real Patient Prices, Insurance Coverage & Financial Assistance Explained - 2026 Drug Cost Analysis

Keytruda Cost in 2026: Real Patient Prices, Insurance Coverage & Financial Assistance Explained

28 views

Keytruda (pembrolizumab) remains one of the most prescribed immunotherapy drugs in the U.S. for advanced cancers — but its cost continues to rise. In 2026, real patient prices can vary from $10,500 to $25,000 per infusion cycle before insurance, depending on dosage and treatment setting. This guide breaks down actual out-of-pocket costs, Medicare and private insurance coverage, and patient financial assistance options available in 2026 to help lower expenses.

Will Zepbound Really Get Cheaper in 2026? What Experts Predict - 2026 Drug Cost Analysis

Will Zepbound Really Get Cheaper in 2026? What Experts Predict

176 views

Wondering if Zepbound will finally become more affordable in 2026? As one of the most discussed weight-loss medications in the U.S., many Americans are hoping for price drops as new competitors and insurance changes emerge. This article explores what experts predict, compares Zepbound’s current and expected costs, and highlights financial assistance programs that could help you save in 2026.

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options - 2026 Drug Cost Analysis

Donanemab Cost in 2026: Alzheimer’s Drug Price, Medicare Coverage & Patient Assistance Options

59 views

Donanemab (Kisunla), Eli Lilly’s Alzheimer’s therapy, is priced around $32,000 per year in 2024–2025 and may rise slightly by 2026. This guide covers the latest projected prices, Medicare and insurance coverage, out-of-pocket estimates, and patient assistance programs available in the U.S. Compare Donanemab vs Leqembi costs, understand CMS registry requirements, and find financial aid options for Alzheimer’s patients.

How Much Does Leqembi Really Cost in 2026? A Complete Alzheimer’s Drug Price & Medicare Guide - 2026 Drug Cost Analysis

How Much Does Leqembi Really Cost in 2026? A Complete Alzheimer’s Drug Price & Medicare Guide

47 views

As Alzheimer’s treatments evolve, Leqembi (lecanemab) stands out as a breakthrough medication—but it comes with a high price tag. In 2026, costs vary depending on insurance coverage, infusion center fees, and Medicare approval. This updated guide reveals current U.S. Leqembi prices, coverage rules, and ways to reduce out-of-pocket expenses through assistance programs and manufacturer discounts.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings